The study of finding appropriate usage/dosage of peramivir on hemodialysis patient, an open-label study.
Not Applicable
- Conditions
- hemodialysis patient
- Registration Number
- JPRN-UMIN000007234
- Lead Sponsor
- Tokyo Women's Medical University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
1) History of hypersensitivity, allergy or serious adverse drug event caused by oseltamivir phosphate, zanamivir hydrate, peramivir hydrate or raninanivir. 2)Patient with contraindications of 1) drugs. 3)Hepatic disorder. 4) Women who are pregnant or suspected to be pregnant and women who are breast-feeding. 5) Any other patients whose condition is inappropriate for the evaluation of this clinical study as judged by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the appropriate usage/dosage of peramivir.
- Secondary Outcome Measures
Name Time Method